---
title: "Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292829202.md"
description: "Daiwa analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H with a HK$25.50 price target, while shares closed at HK$23.60. The stock holds a Strong Buy consensus with an average price target of €3.24. Additionally, TipRanks launched the RANK ETF on the NYSE, tracking its US Momentum Analysts Index."
datetime: "2026-07-16T00:26:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292829202.md)
  - [en](https://longbridge.com/en/news/292829202.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292829202.md)
---

# Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)

Daiwa analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H on July 14 and set a price target of HK$25.50. The company’s shares closed last Tuesday at HK$23.60.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Pharmaron Beijing Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of €3.24.

### Related Stocks

- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)
- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [8601.JP](https://longbridge.com/en/quote/8601.JP.md)

## Related News & Research

- [Goldman Sachs Keeps Their Hold Rating on Royal UNIBREW A/S (0R6Z)](https://longbridge.com/en/news/292727718.md)
- [Roth MKM Reaffirms Their Buy Rating on Trulite (TRUL)](https://longbridge.com/en/news/293045966.md)
- [Macquarie Keeps Their Buy Rating on Ryman Healthcare (RHCGF)](https://longbridge.com/en/news/292848387.md)
- [Canaccord Genuity Sticks to Its Buy Rating for Zegona Communications (ZEG)](https://longbridge.com/en/news/292794122.md)
- [Citi Remains a Buy on Mr Price Group (MRPZF)](https://longbridge.com/en/news/292879006.md)